Institut Catala de Oncologia - Girona

Girona 17007

0 studies enrolling now · 1 studies all time

What they study most

Fallopian Tube Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Cancer

Studies at this site

• Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) — Stopped early